Xiaosheng Liu

h-index24
2papers
1,868citations

2 Papers

11.1CVJul 8Code
Heterogeneity-Adaptive Diffusion Schrodinger Bridge for PET-Guided Whole-Body MRI Translation

Chengbo Wang, Jiacheng Yu, Linjie Bian et al.

While whole-body multimodal medical imaging scanners have been increasingly recognized for more effective medical applications, the excessive long acquisition time in PET-MR scanning is a major obstacle in more efficient clinical practice. Deep learning-based MRI translation provides a potential solution to reduce scan duration. However, current models often focus on specific anatomical regions and face challenges for whole-body scans that consists of highly heterogeneous feature distributions mainly due to (1) different anatomical regions across whole-body, and (2) lesions or pathological tissues. This paper tackles the challenges through a novel Heterogeneity-Adaptive Diffusion Schrodinger Bridge (HA-DSB) framework. By explicitly modeling translation as stochastic transport between source and target distributions, HA-DSB incorporates region context embeddings derived from a vision-language model (VLM) to enable region-specific modeling. To enhance fidelity of the pathological tissue, lesion-aware metabolic prior from PET is integrated directly into the bridge dynamics through a dual-stage guidance mechanism. Specifically, a PET-guided noise modulation module adaptively scales spatial diffusion perturbations during the forward process, while PET features are leveraged during the reverse process to selectively amplify lesion-relevant structures via an attention mechanism. Experiments demonstrate the superiority of our method across different body regions in whole-body MRI translation and show improved translation quality in lesion areas under PET guidance. Our code is available at Github.

5.1IVApr 29, 2025Code
LymphAtlas- A Unified Multimodal Lymphoma Imaging Repository Delivering AI-Enhanced Diagnostic Insight

Jiajun Ding, Beiyao Zhu, Xiaosheng Liu et al.

This study integrates PET metabolic information with CT anatomical structures to establish a 3D multimodal segmentation dataset for lymphoma based on whole-body FDG PET/CT examinations, which bridges the gap of the lack of standardised multimodal segmentation datasets in the field of haematological malignancies. We retrospectively collected 483 examination datasets acquired between March 2011 and May 2024, involving 220 patients (106 non-Hodgkin lymphoma, 42 Hodgkin lymphoma); all data underwent ethical review and were rigorously de-identified. Complete 3D structural information was preserved during data acquisition, preprocessing and annotation, and a high-quality dataset was constructed based on the nnUNet format. By systematic technical validation and evaluation of the preprocessing process, annotation quality and automatic segmentation algorithm, the deep learning model trained based on this dataset is verified to achieve accurate segmentation of lymphoma lesions in PET/CT images with high accuracy, good robustness and reproducibility, which proves the applicability and stability of this dataset in accurate segmentation and quantitative analysis. The deep fusion of PET/CT images achieved with this dataset not only significantly improves the accurate portrayal of the morphology, location and metabolic features of tumour lesions, but also provides solid data support for early diagnosis, clinical staging and personalized treatment, and promotes the development of automated image segmentation and precision medicine based on deep learning. The dataset and related resources are available at https://github.com/SuperD0122/LymphAtlas-.